C-Reactive Protein, Insulin Resistance, and Metabolic Syndrome in a Population With a High Burden of Subclinical Infection
Open Access
- 1 December 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (12), 2312-2314
- https://doi.org/10.2337/dc08-0815
Abstract
OBJECTIVE—To explore relationships between C-reactive protein (CRP), subclinical infection, insulin resistance, and metabolic syndrome. RESEARCH DESIGN AND METHODS—Data from 1,174 Eskimos, aged ≥18 years, from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study were analyzed; 40 participants with diabetes were eliminated. Baseline assessment included interviews, physical exam, and blood and urine sampling. Metabolic syndrome was assessed using Adult Treatment Panel III criteria. CRP and antibodies to common pathogens were measured. RESULTS—Although CRP was related in univariate analyses to insulin resistance and metabolic syndrome, relations were attenuated or eliminated after adjustment for relevant covariates. CRP was not higher among those with impaired fasting glucose (IFG), and pathogen burden was not related to insulin resistance, metabolic syndrome, or IFG. CONCLUSIONS—Pathogen burden and inflammation do not seem to be related to insulin resistance, metabolic syndrome, or IFG in this population. The inflammatory process may reflect insulin resistance or its correlates but most likely is not causative.Keywords
This publication has 13 references indexed in Scilit:
- Obesity, Inflammation, and Insulin ResistanceGastroenterology, 2007
- A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methodsInternational Journal of Circumpolar Health, 2005
- Dietary Intakes Vary with Age among Eskimo Adults of Northwest Alaska in the GOCADAN Study, 2000–20031-3Journal of Nutrition, 2005
- Low-Grade Systemic Inflammation and the Development of Type 2 DiabetesDiabetes, 2003
- Inflammatory Cytokines and the Risk to Develop Type 2 DiabetesDiabetes, 2003
- C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention StudyDiabetes, 2002
- Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 DiabetesDiabetes, 2002
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJama-Journal Of The American Medical Association, 2001
- Body mass index, diabetes, and C-reactive protein among U.S. adults.Diabetes Care, 1999
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985